top
Thousands of cancer patients in England to benefit from new immunotherapy jab
Why this matters: a developing story that could shape the day's news cycle.
Injectable pembrolizumab can treat several types of cancer and can be administered in under two minutes Thousands of patients across England each year will benefit from a new immunotherapy treatment that can be used for several types of cancer, the NHS has announced.The injectable form of pembrolizumab, which can be administered in under two minutes, kills cancer cells by blocking a protein called PD-1, which acts as a brake on immune responses, allowing the immune system to recognise and attack cancer cells. Continue reading...
Article preview — originally published by The Guardian. Full story at the source.
Read full story on The Guardian →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from The Guardian alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop